ZFP36 and metabolic dysfunction-associated steatotic liver disease: Metformin-induced TTP activation inhibited mTORC1 via destabilization of Rheb, which promotes transcription factor-EB nuclear translocation to promote hepatocyte lipophagy, treating obesity-related NAFLD (27).